Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
ES Unit - Lancet, 2005 - thelancet.com
Background Results of previous randomised trials have shown that interventions that lower
LDL cholesterol concentrations can significantly reduce the incidence of coronary heart …
LDL cholesterol concentrations can significantly reduce the incidence of coronary heart …
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
CT Trialists - The Lancet, 2005 - Elsevier
BACKGROUND: Results of previous randomised trials have shown that interventions that
lower LDL cholesterol concentrations can significantly reduce the incidence of coronary …
lower LDL cholesterol concentrations can significantly reduce the incidence of coronary …
[HTML][HTML] The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
B Mihaylova, J Emberson, L Blackwell… - Lancet (London …, 2012 - europepmc.org
Background Statins reduce LDL cholesterol and prevent vascular events, but their net effects
in people at low risk of vascular events remain uncertain. Methods This meta-analysis …
in people at low risk of vascular events remain uncertain. Methods This meta-analysis …
[HTML][HTML] The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
CT Trialists - The Lancet, 2012 - thelancet.com
Background Statins reduce LDL cholesterol and prevent vascular events, but their net effects
in people at low risk of vascular events remain uncertain. Methods This meta-analysis …
in people at low risk of vascular events remain uncertain. Methods This meta-analysis …
Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial data issues from the Interdisciplinary Council on Reducing the …
AM Gotto Jr, SM Grundy - Circulation, 1999 - Am Heart Assoc
The benefit of cholesterol-lowering therapy in the prevention of coronary heart disease
(CHD) is well established. The secondary prevention Scandinavian Simvastatin Survival …
(CHD) is well established. The secondary prevention Scandinavian Simvastatin Survival …
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
CT Trialists - The Lancet, 2015 - Elsevier
Background Whether statin therapy is as effective in women as in men is debated, especially
for primary prevention. We undertook a meta-analysis of statin trials in the Cholesterol …
for primary prevention. We undertook a meta-analysis of statin trials in the Cholesterol …
Efficacy and safety of LDL‐lowering therapy among men and women: meta‐analysis of individual data from 174,000 participants in 27 randomised trials
Cholesterol Treatment Trialists' Collaboration - 2015 - ses.library.usyd.edu.au
Background There has been debate about whether statin therapy is as effective in women
as men, especially for primary prevention. Methods Meta‐analyses were performed on data …
as men, especially for primary prevention. Methods Meta‐analyses were performed on data …
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial
Heart Protection Study Collaborative Group - The Lancet, 2011 - thelancet.com
Background Findings of large randomised trials have shown that lowering LDL cholesterol
with statins reduces vascular morbidity and mortality rapidly, but limited evidence exists …
with statins reduces vascular morbidity and mortality rapidly, but limited evidence exists …
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
CT Trialists - The Lancet, 2008 - thelancet.com
Background Although statin therapy reduces the risk of occlusive vascular events in people
with diabetes mellitus, there is uncertainty about the effects on particular outcomes and …
with diabetes mellitus, there is uncertainty about the effects on particular outcomes and …
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
CT Trialists - The Lancet, 2010 - thelancet.com
Background Lowering of LDL cholesterol with standard statin regimens reduces the risk of
occlusive vascular events in a wide range of individuals. We aimed to assess the safety and …
occlusive vascular events in a wide range of individuals. We aimed to assess the safety and …
相关搜索
- prospective meta analysis
- meta analysis ldl cholesterol
- meta analysis statin therapy
- meta analysis vascular disease
- meta analysis low risk
- meta analysis men and women
- safety of more intensive lowering
- efficacy and safety ldl cholesterol
- statin therapy ldl cholesterol
- vascular disease ldl cholesterol
- low risk ldl cholesterol
- vascular disease statin therapy
- low risk statin therapy